Philippines FDA Slashes Generic Approval Timelines

Cuts Review From 120 To 45 Days As President Urges Lower Prices ‘Similar To India’

 
• By David Wallace
  
Man holding hourglass in hands
The FDA in the Philippines is cutting generic approval timelines • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Regulation

More from Policy & Regulation